Registration is now open for these upcoming webinars.
Diagnosing H. pylori Webinar
Learn more about the bacteria, disease state, and guidelines for diagnosing Helicobacter pylori and review the advantages and disadvantages of various testing methodologies.
NGS for Precision Oncology Testing
Learn about the factors to consider when implementing NGS in a clinical pathology lab and review case studies that demonstrate the benefits of determining the genomic profiles of a variety of cancer types.
Microsatellite Instability Testing and Its Role in Colorectal Cancer
Learn about the current state of MSI testing and review performance data from three different testing technologies.
The Impact of Flexible Panel-Based Solutions for Pathogen Detection
Learn how using syndromic panels for pathogen detection can help you increase efficiency and reduce costs in the lab.
UTI Detection and Antibiotic Stewardship Webinar
Dr. Erin Graf will provide an overview of new approaches to UTI detection and review published studies that compare the new technologies to previous standard methods.
Participation Credit Webinars
Receive participation credit, available through Whitehat Communications, when you watch the following webinars.
Flu Testing Under New FDA Guidelines Webinar
In this webinar, Gregory J. Berry, PhD, D(ABMM), will discuss diagnostic tests that meet the FDA’s requirements and what can be learned from the most recent flu season.
Urinary Tract Pathogen Detection Webinar
This webinar will present the new real-time PCR solution for detecting urinary tract infection (UTI) pathogens in just five hours with greater specificity, sensitivity, accuracy, and efficiency than current culture-based methods.
Clostridium difficile Infection Guideline Updates Webinar
This webinar will review the updated 2017 Clostridium difficile infection (CDI) treatment guidelines and recommendations from the IDSA and the SHEA, demonstrate how those updates apply to patient populations, and identify the role of the microbiology laboratory in preventing CDI.
Anti-Heparin Platelet Factor 4 (PF4) Antibodies: A Potentially Catastrophic Occurrence
Heparin-induced thrombocytopenia (HIT) is a potentially dangerous but reversible condition that can put patients at risk and increase the likelihood of patient readmission. This webinar will explain how following a simple test protocol with patients who receive heparin during their hospital stay can help you diagnose or rule out HIT within an hour.
STAT DNA Testing for Molecular Oncology Applications Webinar
Turnaround time remains a major issue in molecular biomarker testing. This webinar will provide a firsthand perspective about how new technologies can help improve turnaround times for virtually any lab.
Community-Acquired Pneumonia Treatment Webinar
Current treatment practices of community-acquired pneumonia (CAP) expose patients to more antimicrobials than necessary. Learn how rapid diagnostic testing can provide earlier treatment with a focused antimicrobial regimen that targets the identified pathogens, substantially reducing exposure of individuals and hospitals to antimicrobial agents.
Infectious Diseases Webinar
A modern technology and communication system can send the results of diagnostic tests for influenza, RSV, and Strep A to the CDC, state health departments, and healthcare organizations nationwide, providing physicians with accurate and timely information about the status of infectious disease on a community, county or state level.
Flu Reclassification Webinar
Understand the reasons behind the FDA’s recent decision to reclassify rapid influenza diagnostic tests and how this may impact your physician office or clinical laboratory in 2018.
The use of barcodes allows laboratories to improve productivity and patient care, and develop better laboratory practices that lead to enhanced workflows and patient outcomes.
Genital Zoster Infections Webinar
HSV and VZV are common causes of cutaneous and mucocutaneous infections and typically distinguished based upon appearance and anatomic location. Improved testing methods allow for correct detection and diagnosis leading to better treatment and patient counseling.
Gluten-Related Disorders Webinar
To optimize patient management, researchers find there is a need to differentiate gluten-related disorders. This webinar will present an update of our current understanding of the three main forms of reactions to wheat and its byproducts.
Women’s Health Webinar
Urogenital infections like bacterial vaginosis, urinary tract infections, and vaginitis impact over one billion women each year. This webinar will help you understand how to keep your costs to a minimum while maximizing the information obtained from each vaginal specimen.
Vaginitis is one of the most common gynecologic disorders seen in primary care. This webinar will provide clinicians with a practical diagnostic approach to the patient presenting to the office with a vaginal discharge.
Tissue Archiving: Reality, Recommendations and Best Practices
Missing tissue blocks can delay diagnosis and put samples at risk, but a good archive will keep your tissue blocks safe and help you save time.
In clinical oncology, the specimen is precious and demands new, advanced technologies to simultaneously survey hundreds of gene targets, replacing time-consuming and costly single analyte serial testing. Learn how NGS-based molecular testing has revolutionized precision medicine and provides rapid and efficient tumor survey to inform proper treatment planning.
Avoiding CCP False Positives in Rheumatoid Arthritis Diagnosis
Accurate diagnosis of rheumatoid arthritis hinges on physical examination, testing and imaging. Understanding the importance of choosing the proper serological tests is a vital step in ensuring that patients receive the care they need.
Pharmacogenomics by Real-Time PCR
Pharmacogenomics (PGx) research is an increasingly important tool for precision medicine. Learn how it’s being used in the modern lab and how real-time PCR is used to investigate PGx mutations.
Comparing Biomarkers Used in Sepsis Webinar
Determine which marker or group of markers can provide clinicians with effective clinical information both upon presentation and during the course of treatment of the septic patient.